From dry eye to GLP-1s, this year's conference brought a variety of insights from key experts in optometry. Want more ...

Dr. Caldwell is an ocular disease consultant based in Johnstown, Pennsylvania. His primary focus is the diagnosis and management of anterior and posterior segment ocular disease, and he has been a ...

Gromacki said that, at the time of the discussion, there were no FDA-approved drug-eluting lenses in the US. She mentioned ...

Thomas Wong, OD, FAAO, details a session he presented alongside Ronald Gentile, MD, FACS, FASRS, at AAOpt 2026. Thomas Wong, ...

Walline, American Academy of Optometry president, shares this year's conference attendance numbers, clinical pearls, and what ...

IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs ...

Ryzumvi (phentolamine ophthalmic solution 0.75%) is approved for the treatment of presbyopia in adults. It is also approved for pharmacologically induced mydriasis produced by adrenergic agonists or ...

The US FDA Dermatologic and Ophthalmic Drugs Advisory Committee will meet October 30, 2026, to review new drug application ...

Andrew Pucker, OD, PhD, FAAO, FSLS, FBCLA, discussed how oculomics research presented at AAOpt 2026 could eventually support ...

As optometrists, it is our job to determine what is really driving those symptoms. Knowing when to look deeper, taking a more ...